Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells

被引:301
作者
Fehniger, TA
Suzuki, K
Ponnappan, A
VanDeusen, JB
Cooper, MA
Florea, SM
Freud, AG
Robinson, ML
Durbin, J
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma 3718511, Japan
[5] Childrens Hosp, Columbus, OH 43205 USA
[6] Res Inst, Columbus, OH 43205 USA
关键词
interleukin; 15; leukemia; transgenic mice; lymphocytes; inflammation;
D O I
10.1084/jem.193.2.219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammation likely has a role in the early genesis of certain malignancies. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms. Here, we engineered a transgenic mouse to overexpress IL-15 by eliminating these posttranscriptional checkpoints. IL-15 transgenic mice have early expansions in natural killer (NK) and CD8(+) T lymphocytes. Later, these mice develop fatal lymphocytic leukemia with a T-NK phenotype. These data provide novel evidence that leukemia, like certain other cancers, can arise as the result of chronic stimulation by a proinflammatory cytokine.
引用
收藏
页码:219 / 231
页数:13
相关论文
共 52 条
[11]   At the crossroads of inflammation and tumorigenesis [J].
Cordon-Cardo, C ;
Prives, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1367-1370
[12]   LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN [J].
DISANTO, JP ;
MULLER, W ;
GUYGRAND, D ;
FISCHER, A ;
RAJEWSKY, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :377-381
[13]   Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402
[14]   Cutting edge:: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo [J].
Fehniger, TA ;
Yu, HX ;
Cooper, MA ;
Suzuki, K ;
Shah, MH ;
Caligiuri, MA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1643-1647
[15]  
Fehniger TA, 1999, J IMMUNOL, V162, P4511
[16]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[17]   Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion [J].
Gärtner, F ;
Alt, FW ;
Monroe, R ;
Chu, M ;
Sleckman, BP ;
Davidson, L ;
Swat, W .
IMMUNITY, 1999, 10 (05) :537-546
[18]   Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells [J].
Gasser, S ;
Corthésy, P ;
Beerman, F ;
MacDonald, HR ;
Nabholz, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5659-5667
[19]   IDENTIFICATION AND CLONING OF A NOVEL IL-15 BINDING-PROTEIN THAT IS STRUCTURALLY RELATED TO THE ALPHA-CHAIN OF THE IL-2 RECEPTOR [J].
GIRI, JG ;
KUMAKI, S ;
AHDIEH, M ;
FRIEND, DJ ;
LOOMIS, A ;
SHANEBECK, K ;
DUBOSE, R ;
COSMAN, D ;
PARK, LS ;
ANDERSON, DM .
EMBO JOURNAL, 1995, 14 (15) :3654-3663
[20]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830